{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T23:06:54Z","timestamp":1775603214703,"version":"3.50.1"},"reference-count":20,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Oncol"],"DOI":"10.1001\/jamaoncol.2019.6828","type":"journal-article","created":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T15:31:55Z","timestamp":1584027115000},"page":"e196828","source":"Crossref","is-referenced-by-count":63,"title":["Comparison of Carboplatin Plus Pemetrexed Followed by Maintenance Pemetrexed With Docetaxel Monotherapy in Elderly Patients With Advanced Nonsquamous Non\u2013Small Cell Lung Cancer"],"prefix":"10.1001","volume":"6","author":[{"given":"Isamu","family":"Okamoto","sequence":"first","affiliation":[{"name":"Research Institute for Diseases of the Chest, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Nokihara","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine and Rheumatology, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shogo","family":"Nomura","sequence":"additional","affiliation":[{"name":"Japan Clinical Oncology Group (JCOG) Data Center\/Operations Office, National Cancer Center Hospital, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiji","family":"Niho","sequence":"additional","affiliation":[{"name":"Department of Thoracic Oncology, National Cancer Center Hospital East, Chiba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunichi","family":"Sugawara","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, Sendai Kousei Hospital, Miyagi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidehito","family":"Horinouchi","sequence":"additional","affiliation":[{"name":"Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Azuma","sequence":"additional","affiliation":[{"name":"Division of Respirology, Neurology, and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine, Fukuoka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuto","family":"Yoneshima","sequence":"additional","affiliation":[{"name":"Research Institute for Diseases of the Chest, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruyasu","family":"Murakami","sequence":"additional","affiliation":[{"name":"Division of Thoracic Oncology, Shizuoka Cancer Center, Shizuoka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukio","family":"Hosomi","sequence":"additional","affiliation":[{"name":"Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Atagi","sequence":"additional","affiliation":[{"name":"Department of Thoracic Oncology, National Hospital Organization Kinki-chuo Chest Medical Center, Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Ozaki","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Kishiwada City Hospital, Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Horiike","sequence":"additional","affiliation":[{"name":"Department of Thoracic Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuka","family":"Fujita","sequence":"additional","affiliation":[{"name":"National Hospital Organization Asahikawa Medical Center, Asahikawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Okamoto","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Yokohama Municipal Citizen\u2019s Hospital, Kanagawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiko","family":"Ando","sequence":"additional","affiliation":[{"name":"Center for Advanced Medicine and Clinical Research, Nagoya University Hospital, Nagoya, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Internal Medicine III, Wakayama Medical University, Wakayama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichiro","family":"Ohe","sequence":"additional","affiliation":[{"name":"Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Nakagawa","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","published-online":{"date-parts":[[2020,5,14]]},"reference":[{"issue":"3","key":"coi190117r1","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2015-000020","article-title":"Challenge of cancer in the elderly.","volume":"1","author":"Marosi","year":"2016","journal-title":"ESMO Open"},{"issue":"1","key":"coi190117r2","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1093\/jnci\/91.1.66","article-title":"Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small-cell lung cancer.","volume":"91","author":"The Elderly Lung Cancer Vinorelbine Italian Study Group","year":"1999","journal-title":"J Natl Cancer Inst"},{"issue":"22","key":"coi190117r3","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1200\/JCO.2006.06.1044","article-title":"Phase III study of docetaxel compared with vinorelbine in elderly patients with advanced non-small-cell lung cancer: results of the West Japan Thoracic Oncology Group trial (WJTOG 9904).","volume":"24","author":"Kudoh","year":"2006","journal-title":"J Clin Oncol"},{"issue":"5","key":"coi190117r4","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1093\/jnci\/95.5.362","article-title":"Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial.","volume":"95","author":"Gridelli","year":"2003","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"coi190117r5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1093\/annonc\/mdh015","article-title":"A phase II study of cisplatin and docetaxel administered as three consecutive weekly infusions for advanced non-small-cell lung cancer in elderly patients.","volume":"15","author":"Ohe","year":"2004","journal-title":"Ann Oncol"},{"issue":"29","key":"coi190117r6","doi-asserted-by":"publisher","first-page":"4663","DOI":"10.1200\/JCO.2007.12.5708","article-title":"Cisplatin plus gemcitabine or vinorelbine for elderly patients with advanced non small-cell lung cancer: the MILES-2P studies.","volume":"25","author":"Gridelli","year":"2007","journal-title":"J Clin Oncol"},{"issue":"6","key":"coi190117r7","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1200\/JCO.2014.55.8627","article-title":"Randomized phase III trial comparing weekly docetaxel plus cisplatin versus docetaxel monotherapy every 3 weeks in elderly patients with advanced non-small-cell lung cancer: the intergroup trial JCOG0803\/WJOG4307L.","volume":"33","author":"Abe","year":"2015","journal-title":"J Clin Oncol"},{"issue":"25","key":"coi190117r8","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1200\/JCO.2017.76.8390","article-title":"Cisplatin-based first-line treatment of elderly patients with advanced non-small-cell lung cancer: joint analysis of MILES-3 and MILES-4 phase III trials.","volume":"36","author":"Gridelli","year":"2018","journal-title":"J Clin Oncol"},{"issue":"9796","key":"coi190117r9","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/S0140-6736(11)60780-0","article-title":"Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial.","volume":"378","author":"Quoix","year":"2011","journal-title":"Lancet"},{"issue":"21","key":"coi190117r10","doi-asserted-by":"publisher","first-page":"3543","DOI":"10.1200\/JCO.2007.15.0375","article-title":"Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer.","volume":"26","author":"Scagliotti","year":"2008","journal-title":"J Clin Oncol"},{"issue":"3","key":"coi190117r11","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S1470-2045(12)70063-3","article-title":"Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, randomised controlled trial.","volume":"13","author":"Paz-Ares","year":"2012","journal-title":"Lancet Oncol"},{"issue":"5","key":"coi190117r12","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1007\/s10637-013-9941-z","article-title":"Pemetrexed and carboplatin followed by pemetrexed maintenance therapy in chemo-na\u00efve patients with advanced nonsquamous non-small-cell lung cancer.","volume":"31","author":"Okamoto","year":"2013","journal-title":"Invest New Drugs"},{"issue":"4","key":"coi190117r13","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1093\/annonc\/mds544","article-title":"Dose escalation study of carboplatin-pemetrexed followed by maintenance pemetrexed for elderly patients with advanced nonsquamous nonsmall-cell lung cancer.","volume":"24","author":"Tamiya","year":"2013","journal-title":"Ann Oncol"},{"issue":"1","key":"coi190117r14","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s12032-015-0715-7","article-title":"A phase II study of pemetrexed plus carboplatin followed by maintenance pemetrexed as first-line chemotherapy for elderly patients with advanced non-squamous non-small cell lung cancer.","volume":"33","author":"Tamiya","year":"2016","journal-title":"Med Oncol"},{"issue":"23","key":"coi190117r15","doi-asserted-by":"publisher","first-page":"5555","DOI":"10.1002\/cncr.25332","article-title":"Risk of mortality in patients with cancer who experience febrile neutropenia.","volume":"116","author":"Lyman","year":"2010","journal-title":"Cancer"},{"issue":"2","key":"coi190117r16","doi-asserted-by":"publisher","first-page":"e163","DOI":"10.1016\/j.cllc.2017.10.013","article-title":"Analysis of factors associated with in-hospital mortality in lung cancer chemotherapy patients with neutropenia.","volume":"19","author":"Cupp","year":"2018","journal-title":"Clin Lung Cancer"},{"issue":"19","key":"coi190117r17","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1056\/NEJMoa1606774","article-title":"Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer.","volume":"375","author":"Reck","year":"2016","journal-title":"N Engl J Med"},{"issue":"22","key":"coi190117r18","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1056\/NEJMoa1801005","article-title":"Pembrolizumab plus chemotherapy in metastatic non-small-cell lung cancer.","volume":"378","author":"Gandhi","year":"2018","journal-title":"N Engl J Med"},{"issue":"23","key":"coi190117r19","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1093\/jnci\/djp369","article-title":"Detecting an overall survival benefit that is derived from progression-free survival.","volume":"101","author":"Broglio","year":"2009","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"coi190117r20","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1093\/annonc\/mdr487","article-title":"Postprogression survival for first-line chemotherapy of patients with advanced non-small-cell lung cancer.","volume":"23","author":"Hayashi","year":"2012","journal-title":"Ann Oncol"}],"container-title":["JAMA Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/articlepdf\/2762583\/jamaoncology_okamoto_2020_oi_190117.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T03:20:09Z","timestamp":1589512809000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/fullarticle\/2762583"}},"subtitle":["A Phase 3 Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2020,5,14]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoncol.2019.6828","relation":{},"ISSN":["2374-2437"],"issn-type":[{"value":"2374-2437","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5,14]]}}}